# Butterfly Network

Type: Company (BFLY)

Source: Biotech Intelligence Brief — https://getbiobrief.com/entity/butterfly-network
Canonical HTML page: https://getbiobrief.com/entity/butterfly-network

## Recent coverage (1 stories)

### Q4 2025 Biotech Earnings: Delcath and Peers Face Critical Commercial Milestones
2026-02-25 15:07:22 · Sentiment: Neutral · Impact: 5/10 · Sources: 4

As the Q4 2025 earnings season commences, Delcath Systems, Butterfly Network, Heron Therapeutics, and Lantheus Holdings are under intense scrutiny regarding their commercial execution and path to profitability. Investors are particularly focused on Delcath's HEPZATO KIT rollout and Lantheus's ability to maintain its dominance in the competitive radiopharmaceutical market.
Full story: https://getbiobrief.com/story/biotech-pharma-q4-2025-earnings-preview-delcath-lantheus

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getbiobrief.com/guides/methodology for the full editorial methodology.